Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 6:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 45 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Operative Bleeding Clear all

Conditions: Alagille Syndrome, Pulmonary Artery Stenoses, Acquired Von Willebrand Disease
Interventions: Assessment for bleeding disorder with tailored post-operative care; Other
Lead sponsor: Stanford University; Other
Eligibility: Up to 17 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: BPH With Urinary Obstruction, BPH, Hematuria, Same Day Discharge
Interventions: Furosemide; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 89 Years · Male only
Enrollment: 138 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Osteoarthritis, Hip, Blood Loss
Interventions: Werewolf Fastseal 6.0; Device
Lead sponsor: North Texas Medical Research Institute, PLLC; Other
Eligibility: 21 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Rockwall, Texas • Rowlett, Texas

Conditions: Nasal Sinus; Inflammation, Opioid Abuse, Pain, Postoperative
Interventions: Ibuprofen 600Mg Tablet, Standard Regimen | Tylenol; Drug · Other
Lead sponsor: University of Nebraska; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Omaha, Nebraska • Cincinnati, Ohio

Conditions: Blood Loss, Surgical
Interventions: Saline irrigation; Procedure
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Burns
Interventions: Recombinant Factor VIIa, Placebo; Drug
Lead sponsor: United States Army Institute of Surgical Research; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Blood Loss Massive, Post Operative Hemorrhage
Interventions: Quantra System; Device
Lead sponsor: HemoSonics LLC; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Endometriosis, Fibroids, Adenomyosis, Pelvic Pain, Abnormal Uterine Bleeding, Adnexal Mass, Minimally Invasive Gynecologic Surgery, Hysterectomy, Myomectomy, Ovarian Cystectomy, Adnexal Surgery
Interventions: educational video; Other
Lead sponsor: UConn Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Clopidogrel
Interventions: Clopidogrel, Discontinue Clopidogrel; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Postoperative Bleeding, Patient Satisfaction, Complications, Operative Time
Interventions: Angle stitch; Procedure
Lead sponsor: Texas Tech University Health Sciences Center, El Paso; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Venous Thrombosis Deep (Limbs), Surgical Blood Loss
Interventions: Enoxaparin Injectable Product, Sodium chloride; Drug
Lead sponsor: Valleywise Health; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Post-operative Complications, Surgical Site Infection, Surgical Wound Infection
Interventions: Prevena™ Incision Management System (PIMS), Standard-of-care Dressing; Device
Lead sponsor: KCI USA, Inc; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Abdomen Hernia
Interventions: Prevena, Prineo, Traditional; Device · Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Shoulder Arthroscopy, Operative Bleeding, Postoperative Pain
Interventions: Tranexamic acid; Drug
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 18 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hip Pain Chronic, Hip Impingement Syndrome, Hip Injuries, Blood Loss, Femoro Acetabular Impingement
Interventions: Tranexamic acid, Placebo; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Rhinosinusitis Chronic, Sinus Cancer, Sinus Polyp, Encephalocele
Interventions: Tranexamic acid injection, Total Intravenous Anesthesia, Inhalational isoflurane; Drug
Lead sponsor: Our Lady of the Lake Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Hemorrhage, Surgical, Tonsillar Bleeding
Interventions: Tranexamic Acid Injectable Product, Normal Saline; Drug · Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 2 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Davis, California • Providence, Rhode Island • San Antonio, Texas

Conditions: Intraoperative Bleeding
Interventions: BioFoam Surgical Matrix, Gelfoam Plus; Device
Lead sponsor: CryoLife, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Palo Alto, California • Seattle, Washington

Conditions: Acute Blood Loss Anemia, Postoperative Pain, Pregnancy
Interventions: non-dissection of inferior rectus sheath, control; Procedure
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hemorrhoids Internal, Hemorrhoids Second Degree, Hemorrhoids Third Degree
Interventions: Rectal Artery Embolization, Operative Hemorrhoidectomy; Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Perforated Eardrum
Interventions: Isoflurane Inhalant Product, Sevoflurane inhalant product, Propofol injection, Remifentanil Injection; Drug
Lead sponsor: Our Lady of the Lake Hospital; Other
Eligibility: 0 Years to 100 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Atrial Fibrillation New Onset, Hemorrhage, Prolonged QTc Interval, Ventricular Tachycardia, Medical Care; Complications, Late Effect of Complications
Interventions: Ranolazine, Placebo; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Staten Island, New York

Conditions: Diabetic Retinopathy, Vitreous Hemorrhage Due to Diabetes Mellitus
Interventions: Faricimab Injection, sham treatment; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Chronic Subdural Hematoma
Interventions: Dextrose 5% W/ Sodium Chloride 0.225%; Drug
Lead sponsor: Carilion Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Roanoke, Virginia

Search by objective public record fields.

Decreasing Hemorrhage Risk in Children With Alagille Syndrome

Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

Bipolar Sealer for Reduction of Blood Loss in Anterior Total Hip Arthroplasties

Pain Management Following Sinus Surgery

Mediastinal Temperature and Post-operative Bleeding

Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn

Evaluation of the Quantra QStat System in Obstetric Patients

Impact of Educational Videos on Pre-operative Anxiety

Does Continued Use of Clopidogrel Into Surgery Cause Increased Perioperative Bleeding?

Reducing Postoperative Bleeding After Hysterectomy Via Independent Closure of Vaginal Cuff Angles

Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures

The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions

The Effects of Post-Operative Interventions on Surgical Site Occurrences in AWR

The Effect of Tranexamic Acid (TXA) on Visualization During Shoulder Arthroscopy

Tranexamic Acid (TXA) in Hip Arthroscopy

TIVA vs TXA in Sinus Surgery to Evaluate Operative Blood Loss and Surgical Field Quality

TEAPOT Study Multisite

Adjunctive Application of BioFoam Surgical Matrix in Liver Surgery

Effect of Non-Dissection of the Inferior Rectus Sheath on Intraoperative Blood Loss

Comparing Rectal Artery Embolization and Surgery for Treatment of Bleeding Grade 2 and 3 Internal Hemorrhoids

Inhalational Anesthesia vs TIVA in Endoscopic Tympanoplasty

Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation

Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy

Effect of Different Intravenous Fluids on Post-operative Chronic Subdural Hematoma Size and Recurrence